Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver Disease-Reference-Cited by-同舟云学术

Value of Sustained Virologic Response in Patients with Hepatitis C as a Function of Time to Progression of End-Stage Liver Disease

Published:2016-09-01 Issue:1 Volume:37 Page:61-70
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Ward Thomas,Gordon Jason,Jones Beverley,Bennett Hayley,Webster Samantha,Kalsekar Anupama,Yuan Yong,Brenner Michael,McEwan Phil

Funder

Bristol-Myers Squibb

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0458-z.pdf

Reference61 articles.

1. Public Health England, Health Protection Scotland, Public Health Wales, Public Health Agency. Hepatitis C in the UK: 2014 report. 2014. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/337115/HCV_in_the_UK_2014_24_July.pdf . Accessed 31 Aug 2016.

2. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61:S45–57.

3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2014;60:392–420.

4. World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. 2014. Available from: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/ . Accessed 31 Aug 2016.

5. Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2010;140(1182–1188):e1181.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment;PharmacoEconomics;2021-08-16

2. The Elimination of Hepatitis C as a Public Health Threat;Cold Spring Harbor Perspectives in Medicine;2019-11-11

3. Genetic variation on the NFKB1 genes associates with the outcomes of HCV infection among Chinese Han population;Infection, Genetics and Evolution;2018-11

4. Daclatasvir combined with asunaprevir is a cost-effective and cost-saving treatment for hepatitis C infection in China;Journal of Comparative Effectiveness Research;2018-08

5. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis;European Journal of Gastroenterology & Hepatology;2018-03